Literature DB >> 18992602

Proximal biliary malignancy.

Mohamed Akoad1, Roger Jenkins.   

Abstract

Hilar cholangiocarcinoma is a rare malignancy that occurs at the bifurcation of the bile ducts. Complete surgical excision with negative histologic margins remains the only hope for cure or long-term survival. Because of its location and proximity to the vascular inflow of the liver, surgical resection is technically difficult and may require advanced vascular reconstructions to achieve complete excision. Patients who are not candidates for resection should undergo palliative biliary drainage. The role of neoadjuvant therapy and liver transplantation in the management of hilar cholangiocarcinoma remains to be defined in light of the recent promising results.

Entities:  

Mesh:

Year:  2008        PMID: 18992602     DOI: 10.1016/j.suc.2008.07.012

Source DB:  PubMed          Journal:  Surg Clin North Am        ISSN: 0039-6109            Impact factor:   2.741


  10 in total

1.  Strong expression of CD133 is associated with increased cholangiocarcinoma progression.

Authors:  Kawin Leelawat; Taweesak Thongtawee; Siriluck Narong; Somboon Subwongcharoen; Sa-ad Treepongkaruna
Journal:  World J Gastroenterol       Date:  2011-03-07       Impact factor: 5.742

2.  Induction of MKP-1 prevents the cytotoxic effects of PI3K inhibition in hilar cholangiocarcinoma cells.

Authors:  Kawin Leelawat; Wandee Udomchaiprasertkul; Siriluck Narong; Surang Leelawat
Journal:  J Cancer Res Clin Oncol       Date:  2010-02-10       Impact factor: 4.553

3.  Signet ring cell carcinoma of the extrahepatic bile duct.

Authors:  Eun Young Lee; Chan Kim; Min-Joo Kim; Jung-Yeop Park; Seung-Woo Park; Si-Young Song; Jae-Bock Chung; Hogeun Kim; Seungmin Bang
Journal:  Gut Liver       Date:  2010-09-24       Impact factor: 4.519

4.  Mutual regulation between microRNA-373 and methyl-CpG-binding domain protein 2 in hilar cholangiocarcinoma.

Authors:  Yong-Jun Chen; Jian Luo; Guang-Yao Yang; Kang Yang; Song-Qi Wen; Sheng-Quan Zou
Journal:  World J Gastroenterol       Date:  2012-08-07       Impact factor: 5.742

5.  miR-373 negatively regulates methyl-CpG-binding domain protein 2 (MBD2) in hilar cholangiocarcinoma.

Authors:  Yongjun Chen; Jian Luo; Rui Tian; Huawen Sun; Shengquan Zou
Journal:  Dig Dis Sci       Date:  2010-11-18       Impact factor: 3.199

6.  Elevated CA 19-9 portends poor prognosis in patients undergoing resection of biliary malignancies.

Authors:  Ioannis Hatzaras; Carl Schmidt; Peter Muscarella; W Scott Melvin; E Christopher Ellison; Mark Bloomston
Journal:  HPB (Oxford)       Date:  2010-03       Impact factor: 3.647

7.  Pathological aspects of so called "hilar cholangiocarcinoma".

Authors:  Víctor M Castellano-Megías; Carolina Ibarrola-de Andrés; Francisco Colina-Ruizdelgado
Journal:  World J Gastrointest Oncol       Date:  2013-07-15

8.  Prognostic Impact of the Initial Postoperative CA19-9 Level in Patients with Extrahepatic Bile Duct Cancer.

Authors:  Yuichiro Kato; Shinichiro Takahashi; Naoto Gotohda; Masaru Konishi
Journal:  J Gastrointest Surg       Date:  2016-06-01       Impact factor: 3.452

9.  Signet ring cell carcinoma of the extrahepatic bile duct diagnosed by preoperative biopsy: a case report.

Authors:  Emiri Kita; Akiko Tsujimoto; Kazuyoshi Nakamura; Kentaro Sudo; Taro Hara; Osamu Kainuma; Hiroshi Yamamoto; Makiko Itami; Y Yamaguchi
Journal:  Case Rep Gastroenterol       Date:  2014-11-11

10.  Detection of Primary Malignancy and Metastases with FDG PET/CT in Patients with Cholangiocarcinomas: Lesion-based Comparison with Contrast Enhanced CT.

Authors:  Youssef Elias; Aladin T Mariano; Yang Lu
Journal:  World J Nucl Med       Date:  2016-09
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.